Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination

At the end of 2020, population-based vaccination programs with new generation mRNA-based vaccines began almost all over the world. The aim of the study was to evaluate the titer of anti-SARS-CoV-2 IgG antibodies against the S1 subunit of the virus’s spike protein as a marker of the humoral response...

Descripción completa

Detalles Bibliográficos
Autores principales: Tretyn, Andrzej, Szczepanek, Joanna, Skorupa, Monika, Jarkiewicz-Tretyn, Joanna, Sandomierz, Dorota, Dejewska, Joanna, Ciechanowska, Karolina, Jarkiewicz-Tretyn, Aleksander, Koper, Wojciech, Pałgan, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391384/
https://www.ncbi.nlm.nih.gov/pubmed/34440721
http://dx.doi.org/10.3390/cells10081952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391384/
https://www.ncbi.nlm.nih.gov/pubmed/34440721
http://dx.doi.org/10.3390/cells10081952

Ejemplares similares